Physician profile
Britton S Plemmons
NPI 1093154189
$87,095.14
in general payments reported to CMS, 2019-2025
16 companies · $18K in 2025
The $18K reported for 2025 was more than what 97% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,433 · 2020: $5,534 · 2021: $2,546 · 2022: $10K · 2023: $28K · 2024: $22K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $54K · Travel and Lodging: $9,992 · Food and Beverage: $3,323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $54,025.00 |
| Travel and Lodging | $9,992.41 |
| Food and Beverage | $3,323.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medshape, INC. | $37,959.99 | 2022-2025 | Dynanail Helix, Washer, 15 Mm, Dynanail, Dynanail Mini |
| Trilliant Surgical LLC. | $18,660.68 | 2021-2025 | Arsenal Sinus Support Plate, Arsenal Ankle 10 Hole 1/3 Tubular Plate, Arsenal Ankle |
| Medical Device Business Services, INC. | $10,577.45 | 2019-2022 | |
| Pylant Medical | $7,278.33 | 2019-2025 | |
| Smith+Nephew, INC. | $7,217.79 | 2020-2025 | |
| Stryker Corporation | $2,705.55 | 2020-2025 | Infinity, Prophecy, Inbone |
| Vilex LLC | $1,786.32 | 2023 | |
| Bioventus LLC | $270.87 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Triad Life Sciences INC. | $191.31 | 2022 | |
| Depuy Synthes Sales INC. | $145.60 | 2019 | |
| Convatec INC. | $136.57 | 2023 | |
| Alafair Biosciences, INC. | $63.55 | 2022 | |
| Ossio INC | $51.89 | 2022 | |
| Ferring Pharmaceuticals INC. | $18.87 | 2020 | |
| Ultragenyx Pharmaceutical INC. | $16.90 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $13.47 | 2025 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Britton Plemmons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.